Karim Abdelhamid

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 01, 2024
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.

Victor Joo, Karim Abdelhamid, Alessandra Noto

Pageof 1

Frequent Collaborators

1 joint publications

Douglas Daoudlarian

1 joint publications

Solange Peters

1 joint publications

Olivier Gaide

1 joint publications

Giuseppe Pantaleo